Sasha system aims to expand access to stroke treatment
Paris-based Artedrone has submitted research results for publication, marking a key step toward clinical validation of its Sasha system—an autonomous, magnetic micro-robot designed to perform mechanical thrombectomy outside traditional stroke centers.
Key Points:
- Only a small percentage of stroke patients currently access thrombectomy-capable facilities.
- Sasha enables cardiologists and radiologists at cardiology centers to perform critical stroke interventions.
- The system was tested in in vitro and in vivo models, including porcine cerebral anatomies and human vascular replicas.
- The latest milestone confirmed effective clot retrieval using biological analog and native clots.
CEO Liane Teplitsky, formerly of Zimmer Biomet’s robotics program, emphasized Sasha’s potential to democratize stroke care.
“We’re encouraged by these preclinical results,” said Dr. Frédéric Clarençon of Pitié Salpêtrière Hospital, noting the system’s promise in expanding global access to life-saving stroke procedures.
Follow MEDWIRE.AI for updates on MedTech robotics and stroke innovations.
